Pediatric Neurology
Volume 24, Issue 5 , Pages 352-356, May 2001

Safety, tolerability, and pharmacokinetics of remacemide in children

  • Frank M.C. Besag, MB, ChB

      Affiliations

    • St Piers Lingfield; Surrey, United Kingdom
    • Corresponding Author InformationCommunications should be addressed to: Dr. Besag; Twinwoods Health Resource Centre, Milton Road, Beds, MU41 GAT, UK
    • ,
  • Rosemary E. Newton, MB, BS

      Affiliations

    • The David Lewis Centre; Cheshire, United Kingdom
    • ,
  • Graham E. Blakey, PhD

      Affiliations

    • AstraZeneca R&D Charnwood; Leicestershire, United Kingdom
    • ,
  • Andrew D.P. Dean, PhD, MB, BCh

      Affiliations

    • AstraZeneca R&D Charnwood; Leicestershire, United Kingdom

Received 27 July 2000; accepted 5 February 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0887-8994(01)00256-9

Pediatric Neurology
Volume 24, Issue 5 , Pages 352-356, May 2001

Article Tools

* Image Usage & Resolution